Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis.
about
Unusual causes of cutaneous ulcerationAdverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.Burkholderia cepacia complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case seriesInfliximab for idiopathic deep cutaneous vasculitis refractory to cyclophosphamide.[Medium and large vessel vasculitis].An aetiological & clinicopathological study on cutaneous vasculitis.Presence of neutrophil extracellular traps and antineutrophil cytoplasmic antibodies associated with vasculitides.The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity.Cutaneous vasculitis in breast cancer treated with chemotherapy.Necrotizing vasculitis as a complication of propylthiouracilGastroenterology cases of cutaneous leukocytoclastic vasculitis.Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis.Making necrotizing vasculitis simple.Neutrophilic dermatoses: an update.Direct immunofluorescence for immunobullous and other skin diseases.Circumscribed cicatricial alopecia due to localized sarcoidal granulomas and single-organ granulomatous arteritis: a case report and systematic review of sarcoidal vasculitis.Vasculitic wheel - an algorithmic approach to cutaneous vasculitides.Leukocytoclastic vasculitis in children: clinical characteristics, subtypes, causes and direct immunofluorescence findings of 56 biopsy-confirmed cases.Sibutramine (reductil®)-induced cutaneous leukocytoclastic vasculitis: a case reportPropylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody.[Skin diseases due to systemic vasculitides and vasculopathies].Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban.Cutaneous Leukocytoclastic Vasculitis with Gastrointestinal Involvement after Anti-Tuberculosis Treatment.Anti-myeloperoxidase and anti-cathepsin G antibodies in sulphonamide hypersensitivity.Direct immunofluorescence testing in vasculitis-A single institution experience with Henoch-Schönlein purpura.Red blood cell distribution width as a useful indicator to predict systemic vasculitis in patients with cutaneous vasculitis.Intravascular crystal deposition: an early clue to the diagnosis of type 1 cryoglobulinemic vasculitis.Complement Activation in Inflammatory Skin Diseases.Paraneoplastic cutaneous small-vessel vasculitis as a presentation of recurrent metastatic breast cancer.
P2860
Q24594606-E51B21A1-DF96-4B79-8AD7-1A19113E4777Q33410375-02C23A3E-949A-4859-A9E1-43F063312F1BQ33605645-C8512D28-69FC-4BAD-BCE7-829EF834F732Q34415190-736E9408-DDA0-4D47-8193-32F51B945675Q34976638-E45D7E24-8BD5-4980-B06A-83216C454956Q35838628-2FBB544D-CD23-4267-B10D-D5432B1B86F8Q35999786-783125F7-D1C1-4429-B45A-C7024FF746E5Q36949687-6DE37A87-EE46-4376-B2AC-81553EF89A32Q36963933-B8EA13E0-BBDA-43DE-8712-2374910C298FQ37166973-54390DA5-89FF-4AFF-8E1D-25D6E4894D0BQ37286022-D68F9B02-DB19-4FA0-88D9-0F9BC8165BE8Q37865057-8F0EE33D-7D44-4DE1-83FD-0E6AF6DE42C3Q38154330-C74F2264-671A-4D67-B13C-55A5C675DF39Q38242975-2B377B20-4F0E-4AC2-93F1-FCC7454EB9F0Q38369714-3EC88B11-D5E8-4C21-9489-403D31FF890EQ38480453-16EB7DCA-8066-43C0-918D-A6FBA863FE95Q38619154-DE7549FF-35BA-470A-BA8C-6DDC7E100EBCQ38942476-CE9FB28B-2822-4383-921C-0118D78D80B0Q39577175-9AB5EC2A-035F-4E19-A5A5-5137C5EAABBFQ40189471-0AC9A4B6-DCCB-4C76-A005-335DB42EB01CQ40444642-1C129113-B363-4936-8D99-850303D41E19Q41847071-578C15A6-BF07-4A3D-8CEB-CCBC86BCADF8Q42099760-6271AFAA-AD06-4FE7-B8A3-D9B7CC454E47Q46919841-7EB69372-D816-463D-8D56-9215788C609AQ47850658-6CB3CBCC-39A4-4727-98B1-D835D99603FBQ50459031-4DBFF538-F44D-4E64-91AA-767BB1D64979Q55293430-001647C2-06EB-4290-AC9A-2D2FA71D8DA1Q55354503-147D99D2-191C-462E-A075-4B1B5C8F1EADQ55519149-1F0FD12E-52D3-40B4-8DF1-DF9E792469D4
P2860
Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cutaneous vasculitis update: d ...... sis, evaluation and prognosis.
@ast
Cutaneous vasculitis update: d ...... sis, evaluation and prognosis.
@en
type
label
Cutaneous vasculitis update: d ...... sis, evaluation and prognosis.
@ast
Cutaneous vasculitis update: d ...... sis, evaluation and prognosis.
@en
prefLabel
Cutaneous vasculitis update: d ...... sis, evaluation and prognosis.
@ast
Cutaneous vasculitis update: d ...... sis, evaluation and prognosis.
@en
P2093
P1476
Cutaneous vasculitis update: d ...... sis, evaluation and prognosis.
@en
P2093
Bernard T Ng
J Andrew Carlson
Ko-Ron Chen
P304
P356
10.1097/01.DAD.0000181109.54532.C5
P577
2005-12-01T00:00:00Z